The ICBC Credit Suisse Pharmaceutical ETF seeks to replicate as closely as possible the price and yield performance of the SSE STAR Biomedical Index by investing in a portfolio comprised primarily of Chinese biomed companies
The ICBC Credit Suisse Pharmaceutical ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in China. The ICBC Credit Suisse fund’s base currency is CNY and the share class was registered 08.08.2024 with unique ISIN - CNE100006G64. Main exchange is Shanghai SE and ticker symbol is 588860. The total expense ratio is 0.2%. The ICBC Credit Suisse Pharmaceutical ETF (CNY) pays dividends 1 time(s) per year.